Phase I-II Study of Hypofractionated Simultaneous Integrated Boost With Tomotherapy for Prostate Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 2, 2009, Pages 392-398

  Di Muzio, Nadia ^a   Fiorino, Claudio ^a   Cozzarini, Cesare ^a   Alongi, Filippo ^a   Broggi, Sara ^a   Mangili, Paola ^a   Guazzoni, Giorgio ^a   Valdagni, Riccardo ^b   Calandrino, Riccardo ^a   Fazio, Ferruccio ^a,c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b National Tumour Institute   (Italy)

^c INSTITUTE OF MOLECULAR BIOIMAGING AND PHYSIOLOGY   (Italy)

Author keywords

Acute toxicity; Hypofractionation; Prostate cancer; Simultaneous integrated boost; Tomotherapy

Indexed keywords

ACUTE TOXICITY; HYPOFRACTIONATION; PROSTATE CANCER; SIMULTANEOUS INTEGRATED BOOST; TOMOTHERAPY;

PATIENT MONITORING;

TOXICITY;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PRIORITY JOURNAL; PROCTITIS; PROSTATE CANCER; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION SAFETY; SCORING SYSTEM; TOMOTHERAPY; UROGENITAL SYSTEM;

AGED; DOSE FRACTIONATION; FEMUR HEAD; HUMANS; LYMPHATIC IRRADIATION; MALE; MIDDLE AGED; PELVIS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; SEMINAL VESICLES; URINARY BLADDER;

EID: 67349135763     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.08.038     Document Type: Article

References (35)

1. Pollack A., Smith L.G., and Von Eschenbach A.C. External beam radiotherapy dose response characteristics of 1,127 men with prostate cancer treated in the PSA era. Int J Radiat Oncol Biol Phys 48 (2000) 507-512
2. Zietman A.L., Desilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 294 (2005) 1233-1239
3. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose Phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
4. Peeters S.T.H., Heemsbergen W.D., Koper P.C.M., et al. Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomize Phase III trial comparing 68Gy of radiotherapy with 78Gy. J Clin Oncol 24 (2006) 1990-1996
5. Brenner D.J., Marinez A.A., Edmundson G.K., et al. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys 52 (2002) 6-13
6. Brenner D.J., and Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 43 (1999) 1095-1101
7. Brenner D.J. Toward optimal external-beam fractionation for prostate cancer. Int J Radiat Oncol Biol Phys 48 (2000) 315-316
8. Fowler J.F., Chappell R., and Ritter M. Is α/β for prostate tumors really low?. Int J Radiat Oncol Biol Phys 50 (2001) 1021-1031
9. Logue J.P., Cowan R.A., and Hendry J.H. Hypofractionation for prostate cancer. Int J Radiat Oncol Biol Phys 49 (2001) 1522
10. Fowler J.F., Chappell R.J., and Ritter M.A. The prospects for new treatments for prostate cancer. Int J Radiat Oncol Biol Phys 52 (2002) 3-5
11. Nahum A.E., Movsas B., Horwitz E.M., et al. Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: Implications for the alpha/beta ratio. Int J Radiat Oncol Biol Phys 572 (2003) 391-401
12. Yan D., Lockman D., Brabbins D., et al. An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer. Int J Radiat Oncol Biol Phys 48 (2000) 289-302
13. Wong J.R., Grimm L., Uematsu M., et al. Image-guided radiotherapy for prostate cancer by CT-linear accelerator combination: Prostate movements and dosimetric consideration. Int J Radiat Oncol Biol Phys 61 (2005) 561-569
14. Roach M., De Silvio C., Lawton C.A., et al. Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression. Radiation Therapy Oncology Group 9413. J Clin Oncol 21 (2003) 1904-1911
15. Lawton CA, De Silvio M, Roach M, et al. An update of the Phase III trial comparing whole-pelvic (WP) to prostate-only (PO) radiotherapy and neoadjuvant to adjuvant total androgen suppression (TAS): Update analysis of RTOG94-13. Proceedings of 47th annual ASTRO Meeting. Denver, CO, October 16-20, 2005. p. 519.
16. Mackie T.R., Kapatoes J., Ruchala K., et al. Image guidance for precise conformal radiotherapy. Int J Radiat Oncol Biol Phys 56 (2003) 89-105
17. Grigorov G., Kron T., Wong E., et al. Optimization of helical tomotherapy treatment plans for prostate cancer. Phys Med Biol 48 (2003) 1933-1943
18. Shepard D.M., Olivera G.H., Reckwerdt P.J., et al. Iterative approaches to dose optimisation in tomotherapy. Phys Med Biol 45 (2000) 69-90
19. Fiorino C., Cozzarini C., Vavassori V., et al. Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: Analysis of a large group of patients pooled from three institutions. Radiother Oncol 64 (2002) 1-12
20. Fiorino C., Sanguineti G., Cozzarini C., et al. Rectal dose-volume constraints in high-dose conformal radiotherapy for localized prostate cancer. J Radiat Oncol Biol Phys 57 (2003) 953-962
21. Fiorino C., Fellin G., Rancati T., et al. Clinical and dosimetric predictors of late rectal syndrome after 3DCRT for localized prostate cancer: Preliminary results of a multicenter prospective study. Int J Radiat Oncol Biol Phys 70 (2008) 1130-1137
22. Fiorino C., Di Muzio N., Broggi S., et al. Evidence of limited motion of the prostate by careful emptying of the rectum as assessed by daily MVCT image-guidance with helical tomotherapy. Int J Radiat Oncol Biol Phys 7 (2008) 611-617
23. Keiler L., Dobbins D., Kulasekere R., et al. Tomotherapy for prostate adenocarcinoma: A report on acute toxicity. Radiother Oncol 84 (2007) 171-176
24. Soete G., Arcangeli S., De Meerleer G., et al. Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: Report on acute toxicity. Radiother Oncol 80 (2006) 78-81
25. Junius S., Haustermans K., Bussels B., et al. Hypofractionated intensity modulated irradiation for localized prostate cancer, results from a Phase I/II feasibility study. Radiat Oncol 2 (2007) 29
26. Vavassori V., Fiorino C., Rancati T., et al. Predictors for rectal and intestinal acute toxicities during prostate cancer high-dose 3D-CRT: Results of a prospective multicenter study. Int J Radiat Oncol Biol Phys 66 (2007) 1401-1410
27. Peeters S.T., Hoogeman M.S., Heemsbergen W.D., et al. Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys 61 (2005) 1019-1034
28. Valdagni R., Rancati T., Fiorino C., et al. Development of a set of nomograms to predict acute lower gastrointestinal toxicity for prostate cancer 3DCRT. Int J Radiat Oncol Biol Phys 71 (2008) 1065-1073
29. Fiorino C., Alongi F., Broggi S., et al. Physics aspects of prostate tomotherapy: Planning optimization and image-guidance issues. Acta Oncol 47 (2008) 1309-1316
30. Kupelian P.A., Willoughby T.R., Reddy C.A., et al. Hypofractionated intensity-modulated radiotherapy (70Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland clinic experience. Int J Radiat Oncol Biol Phys 68 (2007) 1424-1430
31. Martin J.M., Rosewall T., Bayley A., et al. Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma. Int J Radiat Oncol Biol Phys 69 (2007) 1084-1089
32. Pollack A., Hanlon A.L., Horwitz E.M., et al. Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose-escalation trial. Int J Radiat Oncol Biol Phys 64 (2006) 518-526
33. Muren L.P., Wasbø H.S.I., et al. Intensity-modulated radiotherapy of pelvic lymph nodes in locally advanced prostate cancer: Planning procedures and early experiences. Int J Radiat Oncol Biol Phys 71 (2008) 1034-1041
34. Arcangeli S., Saracino B., Petrongari M.G., et al. Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area. Radiother Oncol 84 (2007) 148-155
35. Cozzarini C., Fiorno C., Di Muzio N., et al. Significant reduction of acute toxicity following pelvic irradiation with helical tomotherapy in patients with localized prostate cancer. Radiother Oncol 84 (2007) 164-170